Reference: Botha, Z. (2021). To whom it may concern: Herewith report on the findings of patients that had the Pfizer vaccine. [Unpublished manuscript]. Summary: The report details observations from a practitioner treating over thirty patients who experienced significant health issues following the Pfizer Covid vaccine between June and September 2021. Symptoms reported included severe headaches, […]
Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review evaluates COVID-19 mRNA vaccines from an Australian perspective, focusing on their safety and efficacy. The authors discuss initial promises versus actual outcomes, citing serious side effects—including deaths—from collected case reports. They
Reference: Pfizer. (2021). Comirnaty 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) tozinameran: Package leaflet. Retrieved from [insert URL here] Summary: Comirnaty is a COVID-19 mRNA vaccine designed to prevent illness caused by the SARS-CoV-2 virus, approved for adults and adolescents aged 12 and over. It functions by stimulating the immune
Reference: Canadian COVID Care Alliance. (2021). Dispelling the myth of “a pandemic of the unvaccinated.” Retrieved from https://canadiancovidcarealliance.org Summary: The Canadian COVID Care Alliance, comprising over 500 independent healthcare professionals, challenges the narrative that the COVID-19 pandemic is predominantly a crisis among the unvaccinated. The article argues that vaccination rates were high, yet COVID-19 cases
Reference: American Heart Association. (2017). Title of the article. Journal of the American Heart Association, 6. https://www.ahajournals.org Summary: The article published in the Journal of the American Heart Association (JAHA) in 2017 explores significant advancements in cardiovascular research. It discusses the role of genetics in heart disease, highlighting how specific genetic markers can predict susceptibility
Reference: King’s College London. (2021). COVID-19 infections among vaccinated individuals: A rising concern. ZOE COVID Study. Summary: A study from King’s College London revealed that as of July 15, 2021, daily symptomatic COVID-19 cases among vaccinated individuals in the UK averaged 15,537, marking a 40% increase from the previous week. Concurrently, unvaccinated cases decreased by
Reference: Botha, Z. (2023). Observations on health issues post-COVID vaccination: A report. Summary: Dr Zandré Botha reports findings from over fifty patients who experienced significant health issues following the Pfizer and Johnson & Johnson COVID-19 vaccines. Symptoms observed included severe headaches, nerve pain, paranoia, hypertension, blood clots, fatigue, and shortness of breath, among others. Blood
This interview will be broadcast during the live edition of Die GROOT Ontbyt on Wednesday morning, 4 December 2024. It has been a few years since South Africans were advised by the Department of Health to receive the COVID vaccinations. Questions still arise about the research, effectiveness, and side effects among many South Africans. To
Reference: Edeling, H. (2024). Ethical and scientific considerations for Mpox vaccination programs in Africa. SAVIMS. Summary: The article by Dr. Herman Edeling discusses critical ethical and scientific considerations surrounding Mpox vaccination programmes in Africa. It highlights the need for comprehensive clinical assessments and accurate differential diagnoses for blistering skin disorders, emphasising the limitations of current
Reference: World Health Organization. (2024). Mpox. Retrieved from https://www.who.int/news-room/fact-sheets/detail/mpox Summary: Mpox, formerly known as monkeypox, is a viral infection caused by the monkeypox virus, belonging to the Orthopoxvirus genus. The disease presents with symptoms such as fever, rash, headache, muscle pain, and swollen lymph nodes, lasting typically 2–4 weeks. Transmission occurs via close contact with